Search results
Dec 19, 2022 · Research has shown that esketamine can significantly reduce depression symptoms — relief that can last weeks after treatment ends. Though they’re far from perfect treatments, ketamine and esketamine mark a breakthrough, as they’re the only fast-acting antidepressants available.
Nov 1, 2022 · Ketamine offers a new, fast-acting approach to relieving treatment-resistant depression. Learn the research-backed benefits and how to try it.
Dec 29, 2023 · Is ketamine a treatment for depression? What are the risks? Learn about the uses, benefits, and side effects of ketamine.
Feb 15, 2024 · Ketamine has been used for decades as an anesthetic, and in 2019 an inhaled version of it was approved by the FDA for treatment-resistant depression. But it is generally prescribed only when other treatments have not been effective.
Apr 15, 2024 · In 2019, the Food and Drug Administration (FDA) approved esketamine as a treatment for forms of depression that haven’t improved with standard antidepressants (like citalopram/Celexa or...
Apr 15, 2022 · In 2019, esketamine received FDA approval as an adjunctive treatment for treatment-resistant depression (TRD) in adults. Esketamine was approved under a risk evaluation and mitigation strategy (REMS) that requires administration under medical supervision.
Apr 30, 2019 · Earlier this year, the FDA approved a form of the drug ketamine to treat depression. Ketamine is a fast-acting antidepressant that relieves depressive symptoms in hours instead of the weeks or longer that previous drugs required.
